
Final Trades: Capital One, UnitedHealth, Regeneron and Alibaba
The Investment Committee give you their top stocks to watch for the second half.
Loading news...

The Investment Committee give you their top stocks to watch for the second half.

UnitedHealth Group (UNH) stock fell as much as 3% in premarket trading Monday after a Senate committee report highlighted the insurer's use of âaggressive tac

UnitedHealth Group's aggressive Medicare Advantage strategies under investigation by Senate Judiciary Committee.

--(BUSINESS WIRE)--UnitedHealth Group today announced the release of two new, independent commissioned actuarial studies. The findings, from the independent actuarial and research firm Milliman, using estimates of 2025 costs, summarize the value of Medicare Advantage (MA) both to the government and beneficiaries. Milliman found that: MA costs the federal government 9% less than traditional Medicare. MA out-of-pocket costs are 53% less than in traditional Medicare for a non-dual eligible aged-in.

Health insurer UnitedHealth Group used aggressive tactics to gather diagnoses that can boost Medicare Advantage payments, the Wall Street Journal reported on Monday, citing a U.S. Senate committee investigating the company's practices.

Sen. Chuck Grassley launched an investigation last year following Wall Street Journal reports examining the company's Medicare Advantage practices.

With well-publicized losses for companies including UnitedHealth Group NYSE: UNH, Elevance Health NYSE: ELV, and Wegovy and Ozempic maker Novo Nordisk NYSE: NVO, the healthcare sector failed to outperform the broad market last year.

The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite. The index's top payers dish up to 6.8%.

Shares of UnitedHealth Group Incorporated (NYSE: UNH - Get Free Report) have earned an average recommendation of "Moderate Buy" from the thirty research firms that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation, seventeen have given a buy recommendation and

Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its single share price. Analyst projections suggest the top ten Dow Dogs could deliver an average 23.55% net gain by January 2027, with varying risk profiles. Yield-based strategies favor underdogs; price drops or dividend hikes could bring more Dow Dogs into fair-value territory for income-focused investors.

Ferguson Wellman Capital Management Inc. decreased its stake in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 14.4% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,314 shares of the healthcare conglomerate's stock after selling 4,749 shares during

Duncker Streett and Co. Inc. trimmed its position in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 75.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,637 shares of the healthcare conglomerate's stock after selling 8,324 shares during

Health insurance company, Oscar Health Inc. (NYSE: OSCR) is up 6.69% in after-hours trading on Thursday, at $18.04 per share.

Caldwell Trust Co trimmed its stake in UnitedHealth Group Incorporated (NYSE: UNH) by 45.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,907 shares of the healthcare conglomerate's stock after selling 6,582 shares during the quarter. Caldwell Trust Co's holdings

Benjamin Edwards Inc. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 20.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,604 shares of the healthcare conglomerate's stock after buying an additional 8,946 shares during the

Galvin Gaustad and Stein LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 22.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 60,979 shares of the healthcare conglomerate's stock after selling 17,934 shares

The ageless Dow Jones rallied 13% in 2025 and came within a stone's throw of reaching 49,000. Two brand-name Dow components are well-positioned for success in the new year.

An analyst says the insurer is one of his top picks for this young year. He also lifted his price target slightly.

A new report from Hunterbrook Media investigates how the three biggest health care giants in the U.S.— CVS Health Corp. (NASDAQ:CVS), UnitedHealth Group, Inc. (NYSE:UNH) and Cigna Group (NYSE:CI) — are allegedly using shell companies to hide billions of dollars that Hunterbrook says should be used to lower drug prices for patients.

U.S. private equity firm TPG is close to acquiring UnitedHealth's Optum UK business, in a deal worth between 1.2 billion pounds ($1.62 billion) and 1.4 billion pounds, Sky News reported on Tuesday.